« Previous
Next »
Titles
- DSCSA standards for the interoperable exchange of information for tracing of certain human, finished, prescription drugs: guidance for industry1
- Data brief: sexual and reproductive health services among people with employer sponsored insurance1
- Data elements for research on the role of social determinants of health in Coronavirus disease 2019: infection and outcomes in the U.S1
- Data science: NIH needs to implement key workforce planning activities : report to congressional committees1
- Defense health agency: oversight needed to better ensure that children are screened, tested, and treated for lead exposure : report to congressional committees1
- Defense health care: Actions needed to improve billing and collection of debt for civilian emergency care : report to congressional committees1
- Defense health care: Additional assessments needed to determine effects of active duty medical personnel reductions : report to congressional committees1
- Defense health care: DOD assessment needed to ensure TRICARE behavioral health coverage goals are being met : report to congressional committees1
- Defense health care: DOD expects new IT system capabilities to improve other health insurance processing : report to congressional committees1
- Defense health care: Improved monitoring could help ensure completion of mandated reforms : report to congressional committees1
- Defense health care: Prevalence of and efforts to screen and treat mental health conditions in prenatal and postpartum TRICARE beneficiaries : report to congressional committees1
- Definitions of suspect product and illegitimate product for verification obligations under the Drug Supply Chain Security Act: guidance for industry1
- Delays in confirmatory trials for drug applications granted FDA’s accelerated approval raise concerns1
- Delivery reform1
- Demographic characteristics of adults receiving COVID-19 booster vaccinations1
- Denture base resins: performance criteria for safety and performance based pathway : guidance for industry and Food and Drug Administration Staff1
- Despite documented status, many California immigrants have negative perceptions or experiences of public charge policy1
- Development and licensure of vaccines to prevent COVID-19: guidance for industry1
- Development of monoclonal antibody products targeting SARS-CoV-2 for emergency use authorization: guidance for industry1
- Digital health technologies for remote data acquisition in clinical investigations: guidance for industry, investigators, and other stakeholders1